Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TMS, Sep-Nov (3Q) Ordinary Profit Loss Narrows
TMS to Host an Executive Roundtable at WuXi Global Forum 2025 in San Francisco
TMS Issues Letter to Shareholders Highlighting 2024 Accomplishments and Anticipated Milestones for 2025
TMS to participate in Precision AQ Corporate Access Event During J.P.Morgan 2025 Week in San Francisco
TMS Co., Ltd. CEO Takuro Wakabayashi Interviewed on US Internet News Media 'Biotech TV’
Notice Concerning the Patent for which TMS is granted license (US) to use
Publication of the Phase 2a Clinical Trial Results of JX10 (TMS-007) in the American Heart Association and American Stroke Association’s Stroke
[Delayed]Presentation Material for the Six Months Ended August 31,2024
TMS Co., Ltd., First Half Ordinary Profit Loss Widens, June-Augus Ordinary Profit Loss Widens
Non-consolidated Financial Results for the Six Months Ended August 31, 2024 [Japanese GAAP]